In a recent study published in Science,1 Tansley, Khoutorsky et al. unraveled a novel mechanism by which activated microglia can induce pain and pain hypersensitivity. It involves the degradation of perineural nets (PNNs) around neurons in the spinal cord dorsal horn lamina I (Fig. 1).
PNNs are extracellular matrix structures present around specific neuronal cell bodies and nearby neurites, found in the central nervous system, e.g. in the brain cortex as well as in the spinal cord; they are often associated with inhibitory interneurons. PNNs are composed of proteoglycans that are decorated with glycosaminoglycans (GAGs) consisting mainly of chondroitin sulfate, termed chondroitin sulfate proteoglycans.2 Thus, PNNs are negatively charged macromolecules (for structure, see Fig. 1).
Peripheral nerve injury can lead to allodynia, a long-lasting hypersensitivity, e.g. to mechanical or thermal stimuli that normally do not cause pain. Neuropathic pain associated with allodynia and hyperalgesia, i.e. strongly increased sensitivity to pain stimuli, has been estimated to affect up to 10% of the population.3 This type of chronic pain is difficult to treat with current analgesic drugs. Thus, there is a huge medical need to develop novel, efficient therapies for neuropathic pain. Elucidating the underlying pathophysiology is a crucial prerequisite for the subsequent identification of novel drug targets.
Here, Tansley, Khoutorsky et al. performed mouse studies applying a spared nerve injury (SNI) model of allodynia. In this model, two of the three branches of the sciatic nerve are ligated resulting in mechanical (and thermal) hypersensitivity in the paw, with a maximal pain response peaking two to three days after surgery and lasting for at least 14 days; the other paw serves as a control. Upon peripheral nerve injury, microglia in the spinal cord are activated. For the first time, the authors additionally observed a decrease in GAGs (detected with Wisteria floribunda agglutinin that binds selectively to GAG sugar side chains present in chondroitin sulfate proteoglycans and thus in PNNs), while the PNN core protein was still detectable. Three days after the injury, when the pain response was maximal, GAGs could be detected in the lysosomes of microglia indicating that microglia had split off the GAGs from the PNNs and subjected them to lysosomal degradation.
The authors showed that genetically induced depletion of microglia abolished the development of pain hypersensitivity. Moreover, in the absence of microglia, the GAGs were not cut off from the PNNs around lamina I projection neurons.
Another line of evidence confirmed the importance of microglia for the development of pain hypersensitivity in the applied animal model. The chemokine receptor CX3CR1 is known to be involved in microglia activation and stimulation of phagocytotic activity.4 CX3CR1 knockout (KO) mice were subjected to the SNI model. They showed microgliosis comparable to wildtype animals, but had a decreased number of microglial lysosomes indicating reduced phagocytotic activity, and they developed no pain hypersensitivity. This indicates that the phagocytotic activity of microglia was essential for the development of allodynia. Moreover, no PNN degradation, and reduced lysosomal GAG accumulation was observed in these KO mice.
Subsequently, PNNs around lamina I were genetically disrupted, leading to spontaneous pain and thermal pain hypersensitivity. Using a complementary approach, GAGs were selectively removed from lamina I of PNNs by expression of the bacterial enzyme chondroitinase ABC (Fig. 1). This led to spontaneous pain and pain hypersensitivity in the absence of microglial activation.
To study the effects on a cellular level, patch-clamp recordings using spinal cord lamina I preparations surrounded by PNNs were performed ex vivo. The disruption of PNNs after peripheral nerve injury decreased inhibitory inputs form lamina I PNN-positive projection neurons, an effect that was dependent on microglia.
Since recent reports suggested sex differences in the role of microglia with respect to the development of neuropathic pain,5 Tansley, Khoutorsky et al. performed studies in male and female mice. However, no differences were observed.1
Previous studies investigating the role of activated microglia in neuropathic pain often focused on signaling by released molecules, e.g. adenosine triphosphate (ATP) or cytokines. This is the first study showing an (unexpected) enzymatic activity due to microglia activation resulting in the release of sulfoglycosides from PNNs, which are extracellular matrix structures consisting of chrondroitin sulfate proteoglycans, eventually inducing pain hypersensitivity. It remains unclear, how the discovered degradation of PNNs and GAGs leads to the observed changes in neuronal signaling and the induction of pain and allodynia. The described mechanism requires and warrants further study. It might eventually contribute to the discovery of novel targets and drugs for the treatment of neuropathic pain.
References
Tansley, S. et al. Microglia-mediated degradation of perineuronal nets promotes pain. Science 377, 80–86 (2022).
Hayes, A. J. & Melrose, J. Neural tissue homeostasis and repair is regulated via CS and DS proteoglycan motifs. Front Cell Dev. Biol. 9, 696689 (2021).
Colloca, L. et al. Neuropathic pain. Nat. Rev. Dis. Prim. 3, 17002 (2017).
Silva, R. & Malcangio, M. Fractalkine/CX3CR1 pathway in neuropathic pain: an update. Front. Pain. Res. 2, 684684 (2021).
Mapplebeck, J. C. S. et al. Molecules in pain and sex: a developing story. Mol. Brain 10, 9 (2017).
Funding
Open Access funding enabled and organized by Projekt DEAL.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Müller, C.E., Claff, T. Activated microglia nibbling glycosaminoglycans from spinal cord perineural nets: a new mechanism for neuropathic pain. Sig Transduct Target Ther 7, 333 (2022). https://doi.org/10.1038/s41392-022-01162-0
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41392-022-01162-0